Autoantibodies to glial fibrillary acid protein in patients with different forms of cerebral vascular pathology

Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova

Volumn 108, Issue 11, 2008, Pages 58-61

  Kamchatnov, P R ^a   Chugunov, A V ^a   Ruleva, N Yu ^a   Dugin, S F ^a   Buryachkovskaya, L I ^a   Umarova, Kh Ya ^a  

^a NONE

Author keywords

Autoantibodies; Cerebral vascular pathology

Indexed keywords

EID: 57749175809     PISSN: 19977298     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Russian source
2. Russian source
3. Russian source
4. Russian source
5. Aldskogius H., Kozlova E. Central neuron-glial and glial-glial interactions following axon injury. Prog Neurobiol 1998; 55: 1: 1-26.
6. Anand N., Stead L. Neuron-Specific Enolase as a Marker for Acute Ischemic Stroke: A Systematic Review. Cerebrovascular Diseases 2005; 20: 213-219.
7. Becker K., Kindrick D., Lester M. et al. Sensitization to brain antigens after stroke is augmented by lipopolysaccharide.J Cerebral Blood Flow and Metabolism 2005; 25: 1634-1644.
8. Bornstein N., Aronovich B., Korczyn A. et al. Antibodies to brain antigens following stroke. Neurology 2001; 56: 529-530.
9. Dambinova S., Khounteev G., Izykenova G. et al. Blood test detecting autoantibodies to N-methyl-D-aspartate neuroreceptors for evaluation of patients with transient ischemic attack and stroke. Clin Chem 2003; 49: 1752-1762.
10. Foerch C., Singer O., Neumann-Haefelin T. et al. Evaluation of Serum S100B as a Surrogate Marker for Long-term Outcome and Infarct Volume in Acute Middle Cerebral Artery Infarction. Arch Neurol 2005; 62: 1130-1134.
11. Foerch C., Curdt I., Yan B. et al. Serum glial fibrillary acidic protein as a biomarker for intracerebral haemorrhage in patients with acute stroke. J Neurol Neurosurg Psychiat 2006; 77: 181-184.
12. Herrmann M., Vos P., Wunderlich M. et al. Release of glial tissue-specific proteins after acute stroke: a comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein. Stroke 2000; 31: 2670-2677.
13. Ishida K., Kaneko K., Kubota T. et al. Identification and characterization of an anti-glial fibrillary acidic protein antibody with a unique specificity in a demented patient with an autoimmune disorder. J Neurol Sci 1997; 151: 1: 41-48.
14. Kato H., Kogure K., Araki T., Itoyama Y. Astroglial and microglial reactions in the gerbil hippocampus with induced ischemic tolerance. Brain Res 1994; 664: 1/2: 69-76.
15. Konhevskii D.E., Otellin V.A. Grigor'ev I.P. Glial Fibrillary Acidic Protein in Astrocytes in the Human Neocortex. Neurosci Behav Physiol 2005; 35: 8: 789-792.
16. Magri G., Clerici M., Dall'Ara P. et al. Decrease in pathology and progression of scrapie after immunisation with synthetic prion protein peptides in hamsters. Vaccine 2005; 23: 2862-2868.
17. Mecocci P., Parnetti L., Donato R. et al. Serum autoantibodies against glial fibrillary acidic protein in brain aging and senile dementias. Brain Behav Immun 1992; 6: 3: 286-292.
18. Moalem G., Leibowitz-Ami R., Yoles E. et al. Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat Med 1999; 5: 49-55.
19. Mor F., Cohen I. How special is a pathogenic CNS autoantigen? Immunization to many CNS self-antigens does not induce autoimmune disease. J Neuroimmunol 2006; 174: 1-2: 3-11.
20. Poletaev A.B., Morowv S.G., Gnedenko B.B. et al. Serum anti-S100b, anti-GFAP and anti-NGF autoantibodies of IgG class in healthy persons and patients with mental neurological disorders. Autoimmunity 2000; 32: 1: 33-38.
21. Sanna G., Piga M., Terryberry J.W. et al. Central nervous system involvement in systemic lupus erythematosus: cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations. Lupus 2000; 9: 8: 573-583.
22. Schenk D., Barbour R., Dunn W. et al. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 1999; 400: 173-177.
23. Schroeter M., Schiene K., Kraemer M. et al. Astroglial responses in photochemically induced focal ischemia of the rat cortex. Exp Brain Res 1995; 106: 1: 1-6.
24. Si X., Miguel-Hidalgo J., O'Dwyer G. et al. Age-Dependent Reductions in the Level of Glial Fibrillary Acidic Protein in the Prefrontal Cortex in Major Depression. Neuropsychopharmacology 2004; 29: 2088-2096.
25. Stein T.D., Fedynyshyn J.P., Kalil R.E. Circulating autoantibodies recognize and bind dying neurons following injury to the brain. J Neuropathol Exp Neural 2002; 61: 12: 1100-1108.
26. Terryberry J. W., Thor G., Peter J.B. Autoantibodies in neurodegenerative diseases: antigen-specific frequencies and intrathecal analysis. Neurology of Aging 1998; 19: 3: 205-216.
27. Webster M., Knable M., Johnston-Wilson N. et al. Immunohistochemical localization of phosphorylated glial fibrillary acidic protein in the prefrontal cortex and hippocampus from patients with schizophrenia, bipolar disorder, and depression. Brain Behav Immun 2001; 15: 4: 388-400.
28. Wilhelmsson U., Li L., Pekna M. et al. Absence of Glial Fibrillary Acidic Protein and Vimentin Prevents Hypertrophy of Astrocytic Processes and Improves Post-Traumatic Regeneration. J Neuroscience 2004; 24: 21: 5016-5021.
29. Zimmer D.B., Chaplin J., Baldwin A., Rast M. S100-mediated signal transduction in the nervous system and neurological diseases. Cel and Mol Biol 2005; 51: 201-214.